Blood Cancer Treatments in the FDA Pipeline: What Could Come Next

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.

Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.

Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.

In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.

Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.

Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.

A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.